The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER3 expression in metastatic colorectal cancer: Defining the clinicomolecular profile of an emerging target.
 
Alisha Heather Bent
No Relationships to Disclose
 
Dipen M. Maru
Honoraria - GSB Pharma (I)
Research Funding - Daiichi Sankyo/UCB Japan
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb/Medarex
 
Jean-Nicolas Vauthey
No Relationships to Disclose
 
Arvind Dasari
Consulting or Advisory Role - Crinetics Pharmaceuticals; Hutchison MediPharma; Ipsen; Lexicon; Novartis; Personalis; Voluntis
Research Funding - Eisai; Guardant Health; Hutchison MediPharma; Ipsen; Merck; Novartis
 
Benny Johnson
Consulting or Advisory Role - Gritstone Bio; Incyte; Insmed; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Syntrix Biosystems (Inst)
 
Bryan K. Kee
Stock and Other Ownership Interests - Medtronic
 
Christine Megerdichian Parseghian
No Relationships to Disclose
 
David Menter
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - 3D Medicines; Array BioPharma; Bristol-Myers Squibb; Gritstone Bio; Janssen; Janssen; MedImmune; Merck; Novartis; Pfizer; Pfizer; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Van K. Morris
Consulting or Advisory Role - Axiom Healthcare Strategies; Bicara Therapeutics; BioMedical Insights; Boehringer Ingelheim; Incyte; SERVIER
Research Funding - Bicara Therapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Immatics; Pfizer (Inst)
 
Pang-Dian Fan
Employment - Daiichi Sankyo, Inc.
Stock and Other Ownership Interests - Daiichi Sankyo, Inc.
Consulting or Advisory Role - Guidry & East (I)
 
Kumiko Koyama
Employment - Daiichi Sankyo Co., Ltd.
 
Naoyuki Maeda
Employment - Daiichi Sankyo
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Iylon; Lutris; MolecularMatch
Consulting or Advisory Role - Abbvie; Amal Therapeutics; AstraZeneca/MedImmune; Bayer Health; Bicara Therapeutics; Boehringer Ingelheim; Boston Biomedical; Carina Biotech; Daiichi Sankyo; EMD Serono; EMD Serono; Endeavor BioMedicines; Flame Biosciences; Frontier Medicines; Genentech; Genomic Health; Gilead Sciences; GlaxoSmithKline; HalioDx; Holy Stone Healthcare; Inivata; Ipsen; Iylon; Jacobio; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Lutris; Merck; Mirati Therapeutics; Natera; Novartis; Numab; Pfizer; Pierre Fabre; Redx Pharma; Repare Therapeutics; Replimune; Servier; Taiho Pharmaceutical; Xilis
Research Funding - Amgen; Array BioPharma; Biocartis; Daiichi Sankyo; EMD Serono; Genentech/Roche; Guardant Health; Lilly; MedImmune; Novartis; Sanofi
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Eisai
Speakers' Bureau - Bayer
Research Funding - Bayer (Inst); Daiichi Sankyo/Lilly (Inst); Guardant Health (Inst); Roche/Genentech (Inst)